PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,878,000 | +108.3% | 901,143 | +76.0% | 0.00% | +200.0% |
| Q3 2016 | $6,661,000 | +28.2% | 511,978 | +37.1% | 0.00% | 0.0% |
| Q2 2016 | $5,194,000 | +7.8% | 373,419 | +17.6% | 0.00% | 0.0% |
| Q1 2016 | $4,817,000 | -23.5% | 317,504 | -4.3% | 0.00% | 0.0% |
| Q4 2015 | $6,293,000 | +4.8% | 331,758 | +5.0% | 0.00% | -50.0% |
| Q3 2015 | $6,002,000 | -27.0% | 315,878 | -1.0% | 0.00% | 0.0% |
| Q2 2015 | $8,222,000 | +6927.4% | 319,034 | +8418.9% | 0.00% | – |
| Q1 2015 | $117,000 | -24.0% | 3,745 | -6.4% | 0.00% | – |
| Q4 2014 | $154,000 | – | 4,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |